Thursday, August 25, 2016

BRIEF-Moody's says Teva's loss of two copaxone patents is credit negative

* Moody's on Teva Pharmaceutical - there is no change to

Teva Pharmaceutical Industries LTD Baa2 senior unsecured rating

or stable outlook

Source text for Eikon:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)